QIAGEN is bringing tuberculosis experts from around the world together via the Global TB Clinical and Educational Summit from October 13-16, as a persistent disease burden and growing pressures on global health funding put renewed focus on tuberculosis prevention, screening and care, according to an announcement.

Discussions will focus on major challenges facing TB control, including prevention and screening, drug‑resistant and childhood TB, vulnerable populations and access to care. Sessions will also examine the role of interferon-gamma release assays in screening people at increased risk of developing TB disease, including patients receiving kidney dialysis or biologic therapy, immunocompromised patients and older adults.

The theme of the Summit is “One world, one fight: Let’s end TB together,” and it will take place online. An on-site event will take place on October 16 at the Royal College of Physicians in London.

The Summit comes as cuts to international health funding put TB programs under growing pressure. The WHO has warned that reductions in donor funding threaten essential TB prevention as well as diagnostic and treatment services. A key discussion on October 15, “TB at risk – the global consequences of funding cuts and the future of tuberculosis control,” will bring together experts from academia, clinical practice, advocacy and international TB organizations.

The Summit is free to attend and offers CME- and CPD-accredited learning.

Visit QIAGEN for more information